Explore
13D/13G Activist Filings
119,210 resultsSome filings may show "N/A" for ticker if the subject is a private fund, SPAC, or unlisted security.
| Filed ↓ | Ticker | Company | Filer | Form | % Owned | Shares |
|---|---|---|---|---|---|---|
| Nov 14, 2025 | MRUS | Merus N.V. | Paradigm BioCapital Advisors LP | 13G/A | 6.2% | 4.7M |
| Nov 14, 2025 | URGN | UroGen Pharma Ltd. | Paradigm BioCapital Advisors LP | 13G/A | 9.0% | 4.2M |
| Nov 14, 2025 | KYIV | Cohen Circle Acquisition Corp. I | SONA ASSET MANAGEMENT (US) LLC | 13G/A | 0.0% | 0 |
| Nov 14, 2025 | NKTR | NEKTAR THERAPEUTICS | Nantahala Capital Management, LLC | 13G/A | 2.2% | 419K |
| Nov 14, 2025 | CORN | Teucrium Commodity Trust | HIGHLAND GLOBAL ALLOCATION FUND | 13G/A | 0.0% | 0 |
| Nov 14, 2025 | YMAB | Y-mAbs Therapeutics, Inc. | Paradigm BioCapital Advisors LP | 13G/A | 0.0% | 0 |
| Nov 14, 2025 | KPRX | KIORA PHARMACEUTICALS, INC. | Nantahala Capital Management, LLC | 13G/A | 10.0% | 364K |
| Nov 14, 2025 | NSPR | InspireMD, Inc. | NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP | 13G/A | 5.7% | 2.4M |
| Nov 14, 2025 | EVMN | Evommune, Inc. | LSP 7 Cooperatieve U.A. | 13D | 15.7% | 4.9M |
| Nov 14, 2025 | SONM | Sonim Technologies, Inc. | L1 Capital Global Opportunities Master Fund, Ltd. | 13G/A | 0.0% | 0 |
| Nov 14, 2025 | XELB | XCel Brands, Inc. | Potomac Capital Management Inc. | 13G/A | 8.6% | 408K |
| Nov 14, 2025 | CTEV | CLARITEV CORPORATION | Hellman & Friedman Capital Partners VIII, L.P. | 13D/A | 16.4% | 2.7M |
| Nov 14, 2025 | FOUR | Shift4 Payments, Inc. | Durable Capital Partners LP | 13G/A | 8.4% | 5.6M |
| Nov 14, 2025 | TIGO | MILLICOM INTERNATIONAL CELLULAR SA | Atlas Investissement SAS | 13D/A | 42.2% | 70.5M |
| Nov 14, 2025 | RLAY | Relay Therapeutics, Inc. | Commodore Capital LP | 13G/A | 9.9% | 17.0M |
| Nov 14, 2025 | DK | Delek US Holdings, Inc | Ion Asset Management Ltd. | 13G/A | 3.1% | 1.8M |
| Nov 14, 2025 | INSM | INSMED Inc | Darwin Global Management, Ltd. | 13G/A | 9.7% | 20.5M |
| Nov 14, 2025 | SONM | SONIM TECHNOLOGIES INC | 1 Main Capital Management, LLC | 13G/A | 8.2% | 1.5M |
| Nov 14, 2025 | YMM | Full Truck Alliance Co. Ltd. | SB Investment Advisers (UK) Limited | 13G/A | 7.4% | 1.4B |
| Nov 14, 2025 | ROIV | Roivant Sciences Ltd. | SB Investment Advisers (UK) Limited | 13G/A | 5.8% | 40.3M |
| Nov 14, 2025 | LMND | Lemonade, Inc. | SoftBank Group Capital Ltd | 13G/A | 4.8% | 3.6M |
| Nov 14, 2025 | CPNG | Coupang, Inc. | SB Investment Advisers (UK) Limited | 13G/A | 17.3% | 289.5M |
| Nov 14, 2025 | PHVS | Pharvaris N.V. | Bain Capital Life Sciences Fund, L.P. | 13G/A | 3.0% | 1.9M |
| Nov 14, 2025 | GUTS | Fractyl Health, Inc. | Maverick Capital, Ltd. | 13G/A | 3.1% | 4.2M |
| Nov 14, 2025 | DNTH | DIANTHUS THERAPEUTICS, INC. | BCLS Fund III Investments, LP | 13G/A | 3.1% | 1.3M |
| Nov 14, 2025 | YY | JOYY Inc. | Stonehill Capital Management LLC | 13G/A | 2.7% | 27.6M |
| Nov 14, 2025 | N/A | Lyell Immunopharma, Inc. | ARCH Venture Fund IX, L.P. | 13G/A | 13.0% | 2.8M |
| Nov 14, 2025 | SANA | Sana Biotechnology, Inc. | ARCH Venture Fund IX, L.P. | 13G/A | 17.2% | 45.9M |
| Nov 14, 2025 | OCS | Oculis Holding AG | Nan Fung Group Holdings Limited | 13G/A | 4.9% | 2.8M |
| Nov 14, 2025 | BTU | Peabody Energy Corporation | Maverick Capital, Ltd. | 13G/A | 6.7% | 8.2M |
| Nov 14, 2025 | N/A | Pacific Gas & Electric Company | Stonehill Capital Management LLC | 13G/A | 7.9% | 817K |
| Nov 14, 2025 | CRIS | Curis, Inc. | Maverick Capital, Ltd. | 13G/A | 0.4% | 50K |
| Nov 14, 2025 | UNBX | UNITY BIOTECHNOLOGY, INC. | ARCH Venture Fund VII, L.P. | 13G/A | 0.0% | 0 |
| Nov 14, 2025 | CDTX | CIDARA THERAPEUTICS, INC. | BCLS Fund III Investments, LP | 13G/A | 10.0% | 3.0M |
| Nov 14, 2025 | ADAG | Adagene Inc. | Panacea Venture Healthcare Fund II, L.P. | 13G/A | 3.8% | 2.3M |
| Nov 14, 2025 | WBI | WaterBridge Infrastructure LLC | WBR Holdings LLC | 13G | 26.6% | 14.5M |
| Nov 14, 2025 | DOO | BRP Inc. | Bain Capital Integral Investors II, L.P. | 13G/A | 23.2% | 10.5M |
| Nov 14, 2025 | GENI | Genius Sports Limited | Mark Locke | 13G/A | 7.2% | 17.1M |
| Nov 14, 2025 | JCAP | Jefferson Capital, Inc. | JCF IV JCAP Holding L.P. | 13G/A | 75.0% | 43.7M |
| Nov 14, 2025 | SCLX | Scilex Holding Co | Oramed Pharmaceuticals Inc. | 13G/A | 9.9% | 833K |
| Nov 14, 2025 | IPSC | CENTURY THERAPEUTICS, INC. | Bain Capital Life Sciences Opportunities III, LP | 13G/A | 4.1% | 3.5M |
| Nov 14, 2025 | STUB | StubHub Holdings, Inc. | Eric Howard Baker | 13G | 9.4% | 32.7M |
| Nov 14, 2025 | HTFL | Heartflow, Inc. | BCLS Fund III Investments, LP | 13G | 14.9% | 12.4M |
| Nov 14, 2025 | VNOM | Viper Energy Inc. | BX Royal Aggregator LP | 13G | 2.4% | 4.2M |
| Nov 14, 2025 | OI | O-I Glass, Inc. /DE/ | COOPER CREEK PARTNERS MANAGEMENT LLC | 13G/A | 65.0% | 10.1M |
| Nov 14, 2025 | TRVI | Trevi Therapeutics, Inc. | Frazier Life Sciences Public Fund, L.P. | 13G/A | 7.0% | 8.5M |
| Nov 14, 2025 | JBIO | JADE BIOSCIENCES, INC. | Frazier Life Sciences Public Fund, L.P. | 13G/A | 4.2% | 1.4M |
| Nov 14, 2025 | SCNX | Scienture Holdings, Inc. | L1 Capital Global Opportunities Master Fund, Ltd. | 13G/A | 0.0% | 0 |
| Nov 14, 2025 | N/A | Willow Tree Capital Corp | HERSHEY TRUST CO TRUSTEE IN TRUST FOR MILTON HERSHEY SCHOOL | 13G/A | 10.9% | 2.2M |
| Nov 14, 2025 | OM | Outset Medical, Inc. | Durable Capital Partners LP | 13G/A | 7.6% | 1.4M |